Profound Medical (PROF): CEO bought ~$43K

~$43K

Approx. value · 10K sh @ $4.33

575K

Holds after · shares reported

Traded

May 15, 2025

Filed

May 20, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 15, 2025 · this disclosureInsiderCEO purchased ~$43K of PROF shares in the open market

What came next

1. May 16, 2025InsiderCEO purchased ~$57K of PROF shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Profound Medical

OQRO holds no insider, Congress, fund or contract record for Profound Medical dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PROF page.

Other recent filings by Arun Swarup Menawat, CEO

• SEC Form 4 at Profound Medical (PROF)May 20, 2025

The full history of Arun Swarup Menawat, CEO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Profound Medical

• SEC Form 4May 20, 2025
• House Clerk periodic transaction reportAug 26, 2021
• House Clerk periodic transaction reportAug 26, 2021
• House Clerk periodic transaction reportMar 5, 2021
• House Clerk periodic transaction reportMar 5, 2021

Everything OQRO holds on this company is on its PROF page.